RecruitingNCT04359836

A Study to Explore the Role of Gut Flora in COVID-19 Infection

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection


Sponsor

ProgenaBiome

Enrollment

250 participants

Start Date

Apr 16, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female of 18 years of age or older
  • Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening

Exclusion Criteria4

  • Refusal to sign informed consent form
  • History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  • Postoperative stoma, ostomy, or ileoanal pouch
  • Treatment with total parenteral nutrition

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThere is no intervention in this study

There is no intervention in this study


Locations(1)

ProgenaBiome

Ventura, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04359836


Related Trials